Robbie Williams and Jennifer Hudson also performed, with Kylie Jenner and Timothee Chalamet among the celebrities in the crowds.
All Right Reserved. Designed and Developed by Martyn Jones.
Police were called to Osprey Court in Barry at around 2.30am on July 20 after reports of anti-social behaviour.
While dispersing a group at the scene, officers carried out a stop and search and arrested a 15-year-old on suspicion of possession with intent to supply class B drugs.
The teenager has since been released on bail while inquiries continue.
South Wales Police say tackling anti‑social behaviour is a key priority and are encouraging people to use Project Pinpoint to report problems in their communities.
Project Pinpoint is a force campaign designed to make it easier for residents to understand how and where to report anti‑social behaviour, what happens next, and how those reports feed into crime data used to plan local responses.
Reports of ASB can lead to targeted patrols, partnership work with councils and housing providers, and community‑focused initiatives aimed at reducing nuisance and disorder.
The force is urging anyone who witnesses persistent ASB to come forward rather than assuming nothing will be done, reminding people that “every report counts” when it comes to improving safety and quality of life.
Checking your inhaler technique can ensure the medication has maximum benefit (Image: Humphrey Nemar/Getty)
Many people will have experienced the symptoms of asthma such as wheezing, shortness of breath, chest tightness or a persistent cough. Asthma affects millions of people in the UK and, with the right treatment, most patients can manage their symptoms. However, it remains a serious condition leading to around 1,500 deaths and 60,000 emergency hospital admissions every year. Many of these could be prevented through better treatment and the correct day-to-day management.
What is asthma?
Asthma occurs when the airways that carry air into and out of the lungs become inflamed. This makes the airways swollen and sensitive, so they react more strongly to triggers such as viral infections, pollen, house dust mites, cigarette smoke and air pollution.
During an asthma attack, the muscles around the airways tighten, the lining of the airways swells further and extra mucus may be produced. These changes make breathing difficult and can lead to wheezing, coughing and breathlessness.
Asthma can usually be controlled with the right treatment. Understanding how asthma medicines work is one of the most important steps in staying well if you have the condition.
Reliever inhalers are only part of the answer
For many years, the treatment that most people associated with asthma was the blue reliever inhaler, usually containing salbutamol. These inhalers, available by prescription only, work quickly by relaxing the muscles surrounding the airways, allowing them to open within minutes.
They provide rapid relief and remain an important treatment for asthma. However, reliever inhalers treat only one part of the problem. They do not reduce the underlying inflammation that causes asthma.
If inflammation is left untreated, the airways remain swollen and sensitive, making future attacks more likely. While symptoms may improve temporarily, the underlying disease may actually be worsening.
Modern asthma treatment focuses on inflammation
Our understanding of asthma has changed significantly and so has the recommended treatment. Current NHS guidance recommends inhalers that not only relieve symptoms but also treat the underlying inflammation.
These inhalers contain both a reliever medicine and an inhaled corticosteroid which reduces inflammation inside the airways.
For people with mild asthma, this approach is known as anti-inflammatory reliever (AIR) therapy. The inhaler is used only when symptoms occur but every dose provides both immediate symptom relief and treatment of the inflammation.
People whose asthma is more severe may be advised to use maintenance and reliever therapy (MART). With MART, the same inhaler is used every day to keep asthma under control and also whenever symptoms develop. This simplifies treatment while ensuring that inflammation is treated consistently.
Increasing numbers of people are now being prescribed AIR and MART inhalers rather than relying solely on reliever inhalers. This reduces the risk of severe asthma attacks and emergency hospital admissions while providing good day-to-day symptom control.
An important message for anyone with asthma is that frequent use of a reliever inhaler should not be seen as normal. If you find yourself needing your reliever inhaler several times a week, waking at night because of symptoms, or limiting your activities due to breathlessness, your asthma may not be well controlled.
Rather than simply using your inhaler more often, you should arrange a review with your GP practice or asthma nurse to discuss whether your treatment needs adjusting.
Inhalers can now treat the inflammation inside airways (Image: Getty)
Taking control of your asthma
Taking asthma medicines correctly is just as important as having the right prescription. Many people do not use their inhalers properly, meaning that much of the medicine never reaches the lungs.
Your GP practice or asthma nurse can check your technique and make sure you are getting the maximum benefit. Even small improvements can improve asthma control.
Every person with asthma should also have a personalised asthma action plan. This written plan explains which medicines to take every day, how to recognise when asthma is becoming worse, what changes to make to treatment if symptoms increase, and when to seek urgent medical help.
Asthma action plans are available through your GP practice. Templates can also be downloaded from the Asthma + Lung UK website.
There are also lifestyle measures that can help reduce the risk of asthma attacks. Avoiding smoking is one of the most important. Maintaining a healthy weight, exercising regularly, keeping vaccinations such as the annual flu vaccine up to date, and attending regular asthma reviews all contribute to better asthma control.
It is important to recognise when urgent medical attention is needed. If you are becoming increasingly breathless, struggling to speak in full sentences, your reliever inhaler is not providing relief, or your symptoms are rapidly worsening, seek emergency medical help.
Living well with asthma
Modern treatments have transformed the outlook for most people with asthma. Today’s inhalers also treat the inflammation that lies at the heart of asthma, helping to prevent severe attacks.
By using the right inhaler recommended by a clinician, checking your technique, attending reviews and following a personalised asthma action plan, you can greatly improve your asthma control and enjoy an active, healthy life.
BBC Verify examines viral claims the new film will be distorted if not seen on a dedicated screen
A previously recorded slowdown in Arctic sea ice decline has ended, according to a new study, with the largest year-to-year wintertime reduction ever recorded.
In a study published last summer, researchers found that melting sea ice in the Arctic had slowed down over the past 20 years, with no statistically significant decline in its extent recorded between 2005 and 2024.
Given the increase in global temperatures during this period, the finding was surprising.
However, the researchers said natural variations in ocean currents that limit ice melting probably balanced the rise in global temperatures. They said this was only a temporary reprieve and melting was highly likely to start again at about double the long-term rate at some point in the next five to 10 years.
Just two years later, the new study has found the slowdown in sea ice decline is now over.
Using the most recent satellite observations of sea ice coverage, the researchers found that the 2005 to 2024 slowdown was “temporary rather than sustained”.
Dr Duo Chan, lead author of the paper from the University of Southampton’s School of Ocean and Earth Science, said that what “looked like a pause in the early 2020s now appears to have just been a temporary slowdown within a longer-term decline”.
Sea ice area in September, when it reaches its annual minimum, has halved since 1979, when satellite measurements began.
The researchers found that between 2024 and 2025 Arctic sea ice declined by 5.8%. This is the largest year-to-year wintertime drop ever recorded.
Dr Alessandro Silvano, co-author of the paper at the University of Southampton, said this sharp drop in 2025 was unusual, but physically plausible under current Arctic warming.
Because the winter sea ice acts as an insulator between the relatively warm Arctic ocean and the much colder atmosphere, a reduction in ice will mean more ocean heat and moisture will enter the atmosphere.
after newsletter promotion
The authors say this can affect pressure patterns, storm development and large-scale atmospheric circulation, affecting the weather farther south.
Chan said the study acted as a warning of the ongoing climate crisis.
“Short-term recoveries can temporarily obscure the longer-term direction of Arctic sea ice change. The low winter sea ice extents in 2025 and 2026 clearly show that Arctic sea ice loss has not stopped – it is continuing in a warming climate,” he said.
The Liverpool and Newcastle United legend was diagnosed in January with stomach cancer, a disease that affects 6,800 people in Britain each year and claims 3,600 lives over the same period.
Fans were able to see the pop legend while the traffic lights remained on red.
“Nobody really got chance to speak with him,” said Morton.
The tour guide revealed it was not his first encounter with the star, having come across him when he used to work at the Cavern Club.
“We were told not to take photos but I managed to sneak one,” he said.
Sir Paul, who famously first found fame in his home city with The Beatles before they became global superstars, was in the city to present actor Stephen Graham with an award in a ceremony at his performing arts school.
Graham, who grew up in the Merseyside town of Kirkby, will be presented with a companionship of the Liverpool Institute for Performing Arts (LIPA) by the former Beatle and co-founder of the school.
LIPA has other Beatles connections, as it is based at the former Liverpool Institute school attended by Sir Paul and George Harrison and is neighbour to Liverpool Art College, where John Lennon studied.
What the UK ETA actually is
The Electronic Travel Authorisation is a mandatory pre-clearance requirement for visitors to the United Kingdom from eligible countries. It is not a visa. It does not grant entry, it authorises travel to the UK border. The UK Border Authority retains the final decision at the port of entry.
Citizens from over 60 countries, including Australia, Canada, Germany, France, Japan, Singapore and the UAE, are now required to hold a valid UK ETA before travelling.
Key facts travellers often miss:
- Valid for two years from issue (or until your passport expires, whichever comes first)
- Allows multiple entries – each visit can be up to six months
- Linked digitally to your passport – no physical document needed
- Cannot be extended – you must reapply if it expires or your passport changes
Why rejections happen
ETA rejections are not typically about eligibility. The majority of errors that lead to rejection are avoidable with careful preparation.
What separates approved applications from rejected ones is rarely ability. It’s attention to detail at the moment of submission.
Why independent verification exists
The government application process is straightforward for many travellers. For those who want an additional layer of checking before they submit, independent services exist to help.
Independent verification services exist to complement the government process, not replace it. They add a second check at the point where most errors occur: before submission.
Introducing UK Visa Portal
UK Visa Portal is an independent application-checking service built on three principles: trust, simplicity, and support. The service exists to answer the question most travellers ask: “Am I doing this right?”
Trust through transparency
UK Visa Portal is an independent application-checking service. It is not a government body, does not represent applicants to UK authorities, and makes no decisions on eligibility. All fees are shown in full before payment, and the service fee is separate from the government ETA fee. Applicants can also apply directly through gov.uk at no additional cost.
Simplicity in practice
The UK Visa Portal form is built to help you organise your information clearly. Each field is explained, each requirement is outlined, and your uploads are checked against the stated formatting requirements before you proceed.
No jargon. No guessing. No, “what does this field actually want?” moments. The form is designed for people who want to get it right.
Support when you need it
Travellers often need assistance outside of standard business hours, particularly when applying from different time zones. UK Visa Portal operates 24/7 support so help is available whenever you need it.
If you’re unsure about a field, a team member can clarify what it is asking for. If the government requests further information, support is available to help you understand what has been requested. If you simply want to talk through the process, help is there.
How UK Visa Portal works
The process is straightforward:
- Complete your application. Enter your details and pay the service fee. We check everything you have entered for completeness and formatting requirements before your application is processed.
- Your application is processed with the UK Home Office. Your checked application details are sent to the UK Home Office for processing. You will receive your result by email once the Home Office has made a decision.
- Travel with confidence. Your approved ETA is linked to your passport digitally. No printed documents are needed – simply show your passport at the UK border.
Throughout this process, you remain in control. Your data is stored securely and encrypted. It is never sold or shared with third parties for marketing purposes. You receive regular status updates and support is available 24/7 if you have any questions.
Getting it right the first time
The UK ETA is straightforward to apply for. Submitting accurate, complete information from the start means fewer delays and a smoother experience overall.
Whether you apply directly through the UK Government or choose to use an application-checking service, the goal is the same: get it right the first time. That’s what travellers need.
For more information, visit ukvisaportal.com. Support is available 24/7 if you have questions about the ETA or about how the service works.
Recognised and accredited
UK Visa Portal is registered with the International Air Transport Association (IATA) under its Travel Industry Designator Service (TIDS), registration number 96238671. IATA/TIDS registration identifies UK Visa Portal as a registered travel industry intermediary.
UK Visa Portal is also a member of the American Society of Travel Advisors (ASTA), membership number 900406918. ASTA is the world’s largest association of travel professionals. Its members are bound by a shared Code of Ethics covering honesty, transparency, and fair dealing with travellers. Membership connects UK Visa Portal to a global network of vetted travel professionals operating to consistent standards.
These accreditations reflect a commitment to operating transparently and to the standards travellers should expect from any service they trust with their travel documentation.
UK Visa Portal is an independent document and application assistance service. It is not affiliated with or endorsed by the UK Government. UK Visa Portal is not an immigration adviser and does not provide immigration advice. UK Visa Portal provides document checking and application assistance only. You can apply for your UK ETA directly and at no additional cost through gov.uk.
Jeremy revealed his diagnosis in an episode of Clarkson’s Farm (Image: Getty)
Health chiefs are being urged to offer thousands more men pinpoint prostate cancer therapies, similar to those received by Jeremy Clarkson and Lord Cameron. A landmark study found focal therapies that destroy only the cancerous part of the gland were effective and caused fewer side effects than more radical treatments such as surgery. Experts said the research meant more men with early prostate cancer should be offered these more precise treatments.
Former Prime Minister Lord Cameron, 59, said it was “not right” that many are not given this option. He said: “I was fortunate to be able to benefit from a more advanced focal therapy to treat my cancer that reduced the risk of life-changing side effects. Prostate cancer is incredibly common and the way we treat it is changing. We should be doing everything we can to ensure that men across the UK — wherever they live, and whatever their means — can benefit from the latest advances.
“I hope this new evidence helps speed up wider access, so more men can benefit from the focused treatments that I received.”
Jeremy Clarkson, 66, recently revealed he had been treated for early, aggressive prostate cancer with a type of focal therapy called high intensity focused ultrasound (HIFU). This involves using high frequency sound waves to heat and destroy tumour cells.
The Top Gear star said the treatment left the cancerous 10% of his prostate “dead” while preserving the rest.
The study by researchers at Imperial College London followed almost 3,500 men who were treated at 14 UK hospitals. They received either HIFU or another focal therapy, freezing-based treatment (cryotherapy).
Ten years after treatment, just two men had died from their prostate cancer and 3% had seen their disease spread outside the prostate.
Experts said these rates were similar to those seen with more radical surgery or radiotherapy. Of men who had two sessions of focal therapy, only one in 10 needed to have prostatectomy or radiotherapy due to persistent cancer.
This compared to a recurrence rate of around 15-30% for men with similar disease risk who had a prostatectomy or radiotherapy first.
The risk of side effects such as incontinence with focal therapy was around one fifth of that for the other treatments. Just 13–24% of men reported erectile dysfunction three years later — less than half the rate seen after radical treatments.
Focal therapies are offered at only a few NHS centres, mostly in London and the South East. Around 1,000 men access it each year but Prostate Cancer UK estimates up to 15,000 could benefit.
Lord Cameron said it’s ‘not right’ that some men are not offered the therapies (Image: Getty)
The charity is urging the National Institute for Health and Care Excellence (NICE) to review the new evidence and expand access.
Amy Rylance, the charity’s director of health services, equity and improvement, said: “Side effects like incontinence or sexual problems can be devastating, and this is the first long-term study that shows many men could avoid them without increasing the risk their cancer could return.
“But without NICE approval, the sad truth is that thousands of men will have to deal with life-changing side effects simply because of their postcode. That’s completely unacceptable, which is why we’re calling for an urgent review of these treatments.”
Dr Taimur Shah, consultant urologist and associate professor at Imperial, said: “Our study now gives clinicians and patients the long-term evidence they have been waiting for.
“We hope these results will help update the main NICE clinical guidelines so that focal therapy is routinely offered as a first-line choice to men.
“Men who would like to know whether it might be right for them can ask their urologist about referral to a specialist centre that performs these treatments.”
The Government recently £2.8 million in capital funding to expand focal therapy provision and create several new centres.
Health Innovation and Safety Minister Preet Kaur Gill said: “Everyone deserves access to the best possible treatment, and this government is determined to make that a reality.
“This study is a powerful demonstration of what focal therapy can achieve. Our investment of up to £2.8 million, announced earlier this year, will help expand the TRANSFORM trial and ensure more men have access to this treatment through prostate cancer screening.”
A US federal judge has temporarily blocked the proposed $110bn (£85bn) merger between media giants Paramount Skydance and Warner Bros Discovery.
The decision follows a lawsuit brought by a coalition of 12 US states, including California and New York, aiming to halt the deal over concerns it would stifle competition and raise consumer prices.
Prosecutors representing the states said merging two major studios would cause “substantial harm on movie theatres, basic cable distributors, and, ultimately, audiences nationwide”.
In response, the media giants argued that the states had misread the market and that merging would improve streaming efficiency.
US district judge Araceli Martínez-Olguín issued the temporary restraining order on Monday following legals arguments heard last week.
Under the 14-day injunction, neither company can finalise the deal or start joining the businesses together.
In her ruling, the judge noted that the state coalition raised “serious questions” regarding the deal’s impact on movie distribution.
She warned that allowing the merger to proceed now would make it “extraordinarily difficult to unscramble the egg” if the court decided later to block it all together.
Judge Martínez-Olguín also pushed back against the companies’ arguments, highlighting that “public’s vital interest in antitrust enforcement” outweighed any temporary delay to the merger.
She said that Paramount and Warner Bros “will continue to operate as separate, viable companies competing in the marketplace” while legal proceedings continue.
